Information about Apo-Pharman
My details
*
*
*

Apo-Pharman (SRL)

Company information

Status
Active

Enterprise number

BE0892.860.848

VAT liability
Yes
Established
04-10-2007
Last balance sheet year
2025
Company size
Small 0,9 FTE
Commercial name
APO PHARMAN BVBA
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Apo-Pharman

2025 2024 2023 2022
Profit/Loss 61,326 -37,09% 97,475 20,63% 80,802 36,67% 59,124
Equity 422,116 17% 360,791 35,47% 266,315 43,56% 185,514
Gross margin 252,575 -7,99% 274,496 19,41% 229,877 -2,67% 236,179
Employees 0.9 0.9 1.2 1.3

Publications from Apo-Pharman

Date Publication
15-09-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Registered Office - Resignations - Appointments (NL)
19-02-2016 General meeting - Financial Year (NL)
25-10-2007 Constitution (NL)

Frequently asked questions

What is the VAT number of Apo-Pharman?
The VAT number of Apo-Pharman is BE 0892.860.848.
Wat is the PEPPOL ID of Apo-Pharman?
The PEPPOL ID of Apo-Pharman is 0208:0892860848. Log in or start a free trial to see the full overview.
When was Apo-Pharman founded?
Apo-Pharman was founded on 04-10-2007.
What is the address of Apo-Pharman?
The current registered office of Apo-Pharman is located at Dorp 31, 8690 Alveringem.
When was the last time Apo-Pharman filed their annual financial statements?
The most recent financial statements of Apo-Pharman were filed on 23-07-2026.
How many employees does Apo-Pharman have?
There are 0,9 FTEs working at Apo-Pharman according to the staff figures in the most recent financial statements.
What is the annual turnover of Apo-Pharman?
At the time of its most recent financial statements, Apo-Pharman did not publish any turnover figures. Apo-Pharman reported a gross margin of €252,574.58.